PubMed Health⌕ Search

Biomedical subjects

A Yasutake

Publications and source records attributed to A Yasutake.

At least 19 recordsLinked to original sources
PubMed1999

Distribution and retention of mercury in metallothionen-null mice after exposure to mercury vapor.

We studied the role of metallothionein (MT) in the distribution and retention of mercury in the brain, lung, liver and kidney of MT-null and wild-type mice after exposure to mercury (Hg0) vapor. Mice were exposed to Hg0 vapor at 5.5-6.7 mg/m3 for 3 h and killed at 1, 24, 72 or 168 h after exposure. One hour after exposure to Hg0 vapor, there were no differences in mercury concentrations in these organs from MT-null and wild-type mice. However, the elimination rate of mercury from the organs, except the brain, were remarkably faster in MT-null mice than in wild-type mice. MT-I and -II levels in the lung and kidney were increased significantly in wild-type mice but not in MT-null mice at 24 h after exposure to Hg0 vapor. At this time point, over 65% of the mercury was retained in the MT fraction of the cytosol of organs from wild-type mice. In contrast, mercury appeared mainly in the high-molecular-weight protein fractions in the cytosol of organs from MT-null mice. In the brain, a large amount of mercury was bound to MT in both strains of mice immediately after exposure. No difference was observed in the elimination rate of mercury from the brain between both strains of mice. Brain MT levels were elevated slightly in wild-type mice at 168 h after exposure but could not be detected in MT-null mice. These data suggest that no detectable MT-I and -II levels were found in the brain of MT-null mice and that mercury was apparently bound to MT-III. Using MT-null mice, we showed also that MT-III may play an important role in the retention of mercury in the brain.

Administration, Inhalation↗
PubMed1999

Pulmonary toxicity caused by acute exposure to mercury vapor is enhanced in metallothionein-null mice.

This study examined the protective role of metallothionein (MT) against pulmonary damage caused by acute exposure to metallic mercury (Hg0) vapor using MT-null and wild-type mice. Both strains of mice were exposed to Hg0 at 6.6 to 7.5 mg/m3 for 4 hr each day for 3 consecutive days. This dosing protocol was lethal to over 60% of MT-null mice but did not kill any wild-type mice. More severe pulmonary damage was found by histopathological observation in MT-null mice than in wild-type mice. MT levels in the lung were elevated in wild-type mice after Hg0 vapor exposure, and gel filtration of the lung cytosol revealed that most of the mercury was associated with MT. In MT-null mice, MT levels were below the limit of detection (0.2 microg/g tissue) for the MT assay even after exposure. After exposure to Hg0 vapor for 3 consecutive days, the pulmonary mercury levels in wild-type mice were significantly higher than in MT-null mice. These findings suggest that MT plays a protective role against the acute pulmonary toxicity of Hg0 vapor.

Administration, Inhalation↗
PubMed1998

Induction by mercury compounds of brain metallothionein in rats: Hg0 exposure induces long-lived brain metallothionein.

Metallothionein (MT) is one of the stress proteins which can easily be induced by various kind of heavy metals. However, MT in the brain is difficult to induce because of blood-brain barrier impermeability to most heavy metals. In this paper, we have attempted to induce brain MT in rats by exposure to methylmercury (MeHg) or metallic mercury vapor, both of which are known to penetrate the blood-brain barrier and cause neurological damage. Rats treated with MeHg (40 micromol/kg per day x 5 days, p.o.) showed brain Hg levels as high as 18 microg/g with slight neurological signs 10 days after final administration, but brain MT levels remained unchanged. However, rats exposed to Hg vapor for 7 days showed 7-8 microg Hg/g brain tissue 24 h after cessation of exposure. At that time brain MT levels were about twice the control levels. Although brain Hg levels fell gradually with a half-life of 26 days, MT levels induced by Hg exposure remained unchanged for > 2 weeks. Gel fractionation revealed that most Hg was in the brain cytosol fraction and thus bound to MT. Hybridization analysis showed that, despite a significant increase in MT-I and -II mRNA in brain, MT-III mRNA was less affected. Although significant Hg accumulation and MT induction were observed also in kidney and liver of Hg vapor-exposed rats, these decreased more quickly than in brain. The long-lived MT in brain might at least partly be accounted for by longer half-life of Hg accumulated there. The present results showed that exposure to Hg vapor might be a suitable procedure to provide an in vivo model with enhanced brain MT.

Animals↗
PubMed1998

The effect of methylmercury on skeletal muscle in the rat: a histopathological study.

Methylmercury (MeHg)-induced neurotoxicity includes skeletal muscle symptoms (extremity weakness and wasting, muscle cramp) in addition to ataxia and disturbances of sensory and visual function. The underlying mechanisms responsible for the skeletal muscle symptoms are still poorly understood. In this study the effects of MeHg exposure on skeletal muscle were investigated in rats receiving orally administered MeHgCl at 5 mg/kg/day for 12 days. MeHg-treated rats gradually lost body weight and showed muscle weakness and wasting. Seven days after the last MeHg dose, MeHg levels in the skeletal muscle were as high as those in liver, kidney, or cerebrum. The obvious histopathological finding in skeletal muscle was a decrease in mitochondrial enzyme activity. These changes were more prominent in mitochondria-rich soleus muscle than in extensor digitorum longus muscle. Our findings confirm that MeHg exposure disturbs mitochondrial energy metabolism in skeletal muscle.

AMP Deaminase↗
PubMed1997

Chronic effects of methylmercury in rats. I. Biochemical aspects.

To examine chronic effects of methylmercury (MeHg), male Wistar rats were fed on MeHg-contaminated diet, 0, 1 and 5 ppm Hg, under a restricted feeding schedule of 16 g/rat/day for 6 days a week. Rats were killed at 6-month intervals for examination of Hg accumulation, tissue levels of glutathione, metallothionein and lipid peroxide, as well as anti-oxidative enzyme activities. The survival of the 5 ppm Hg group, 50% of which died by the end of 32nd month of the exposure, was somewhat shorter than control and 1 ppm Hg groups, 50% of which survived for 34 months. Although the rats showed no neurological signs or decreased body weight gain even in 5 ppm Hg-exposed group until the end of the 2nd year, crossing of hind limb was evident after 2.5 years in all three groups. Accordingly, the neurological sign observed here possibly due to aging rather than MeHg toxicity. Tissue Hg levels showed a dose-dependent accumulation except for the kidney, where the highest Hg accumulation was observed among tissues examined. Renal Hg levels in the 1 ppm group showed about 40% of those in the 5 ppm group. Significant effects by MeHg were evident only in the kidney, where glutathione and metallothionein levels increased in both MeHg-exposed groups. However, lipid peroxide levels elevated only in 1 ppm group. Among the antioxidative enzymes examined, the renal glutathione peroxidase was found to be the most labile enzyme against MeHg exposure. Renal dysfunction suggested by increased plasma creatinine levels was also significant in 5 ppm Hg rats at 2 years. Furthermore, anemia which would be caused by reduced erythropoietin production in the kidney was also evident in this group. The present study suggested that the kidney was the most susceptible organ against MeHg toxicity under the present exposure schedule and that the renal dysfunction might at least partly account for the shortened survival in 5 ppm Hg rats.

Administration, Oral↗
PubMed1997

Chronic effects of methylmercury in rats. II. Pathological aspects.

Chronic effects of methylmercury (MeHg) were examined pathologically in male Wistar rats fed on diet containing 0, 1 or 5 ppm Hg (as MeHg) for two years. Organs including the central nervous tissues were examined histopathologically using hematoxylin and eosin (H & E), Klüver-Barrera (KB), PAS or phenol-congo red stains. The peripheral nerve system tissues were also examined, using H & E and trichrome stains. Furthermore, immunoglobulins of renal specimens were demonstrated by direct immunofluorescence microscopy. Localization of mercury in the paraffin-embedded sections of the nervous tissue, kidney, liver, pancreas, spleen and testis was demonstrable by the photoemulsion histochemical method. In the 5 ppm group, mercury was readily detectable in tissues of the rats exposed for one year, one and half years, two years and two and half years. Mercury was detected in the cells of the brain such as neurons, neuroglial cells, and phagocytes, and also in most organs, particularly in the epithelium of renal tubules, liver cells, myocardium, in the macrophages of pancreas, spleen and testis. In the 1 ppm group, mercury was detectable in the epithelium of renal tubules and liver cells. Fibrosis of the glomeruli was found in the rat group given a high dose of methylmercury with all experimental methods. Granular IgG, IgM and C3 deposits were demonstrated in the glomeruli by direct immunofluorescence microscopy. The etiology of the pathological changes of glomeruli was suspected to be autoimmune glomerulopathy due to inorganic mercury filtration for a long time. It was difficult to determine the clinical signs and symptoms and pathological changes in the nervous system in spite of the deposition of mercury in the brain.

Administration, Oral↗
PubMed1996

Influence of dietary protein levels on the acute toxicity of methylmercury in mice.

The influence of dietary protein levels on the acute toxicity of methylmercury (MeHg) was investigated using C57BL/6N male mice fed either a 24.8% protein diet (normal protein diet, NPD) or a 7.5% protein diet (low protein diet, LPD). When MeHg was administered to each group of mice, all mice died at a medium or high dose (80 or 120 mumol/kg, respectively) within 16 or 7 days, respectively, but not at a low dose (40 mumol/kg) in both dietary groups. Although no difference was observed in the survival rate at a medium dose, NPD-fed mice died earlier despite lower brain Hg than LPD-fed mice at a high dose. Accordingly, death, in our observations, could not be due to neural damage by MeHg. When a high dose of MeHg was administered to mice, plasma aspartate aminotransferase and alanine aminotransferase activities increased in NPD-fed mice but not in LPD-fed mice in spite of similar hepatic Hg levels. Therefore, the higher susceptibility of the liver could be reason for the shorter survival period in NPD-fed mice. Since plasma creatinine increased within 24 h after MeHg administration at a medium or high dose, renal dysfunction could be a major factor in death. The present results suggest that susceptibility to acute MeHg toxicity was higher in NPD-fed mice than in LPD-fed mice, possibly due to the difference in hepatic susceptibility.

Alanine Transaminase↗
PubMed1996

Methylmercury transport across the placenta via neutral amino acid carrier.

Methylmercury (MeHg) penetrates the placental barrier to affect developing fetuses in the uterus. However, the mechanism of placental MeHg transport is not well defined. To clarify the MeHg transport system that functions in the placenta, pregnant rats were intravenously administered MeHg on day 18 of gestation. The fetal blood was collected from the umbilical cord at 30 and 60 min after the administration, and its mercury concentration was measured. MeHg was found to be rapidly transported to the fetal blood in a time- and dose-dependent manner, and predominantly distributed in the blood cells there. MeHg transport was effectively suppressed by the co-injection of neutral amino acids, i.e., L-methionine and L-phenylalanine, suggesting that MeHg is actively transported as its cysteine conjugate via the neutral amino acid carrier system. The suppression by methionine was not so marked as by phenylalanine. Since methionine administration caused a rapid increase of the cysteine, which functioned as a predominant carrier in MeHg transport, in the maternal plasma, newly synthesized cysteine seemed to accelerate the mercury uptake. Accordingly, the acceleration by the extra cysteine would compensate partly the competitive effect of methionine as a neutral amino acid.

Amino Acid Transport Systems↗
PubMed1994

Influence of dietary levels of protein and sulfur amino acids on the fate of methylmercury in mice.

We previously reported that the fate of methylmercury (MeHg) in mice was affected by dietary protein levels. To study the mechanism of this alteration, we investigated the effect of sulfur amino acid supplement for a lowered protein diet on the fate of MeHg. C57BL/6N male mice were fed on a 24.8% protein diet (normal protein diet, NPD), a 7.5% protein diet (low protein diet, LPD), or LPD supplemented by methionine and cystine so as maintain the normal levels (amino acid supplemented diet, ASD) for 5 days. NPD-fed mice were used as controls. The mice were orally administered MeHg chloride (20 mumol/kg), and were examined after 24 h distribution and excretion of Hg. The Hg level in brain increased with LPD feeding and was further enhanced by ASD feeding. The hepatic Hg level increased only with ASD feeding. Although Hg levels in kidney, blood and plasma did not change with LPD feeding, these decreased with ASD feeding. The urinary Hg level that decreased with LPD feeding was recovered and exceeded by far the control levels with ASD feeding. When mice were intravenously injected with MeHg-bovine serum albumin, the Hg uptake rate in the brain increased in LPD-fed mice and was further enhanced in ASD-fed mice. The brain uptake of intravenously injected L-[14C]phenylalanine was also accelerated with LPD or ASD feeding, which indicated that LPD or ASD feeding increased activity of neutral amino acid transport in the brain. This would cause increased Hg uptake in the brain, since MeHg reaches the brain through this transport system. Hg ratio in plasma low molecular weight fraction increased in ASD-fed mice, but not in LPD-fed mice. This might contribute to the further enhanced Hg uptake in the brain with ASD feeding. Analysis of thiol compounds in plasma and urine revealed increased levels with ASD feeding. The present results suggest that insufficiency of sulfur amino acids in LPD is one reason for the alteration in the fate of MeHg induced by LPD feeding. It is also suggested that the change in neutral amino acid transport caused by LPD feeding is involved in the alteration in the fate of MeHg.

Animals↗
PubMed1994

Mechanism of methylmercury efflux from cultured astrocytes.

To study the mechanism of methylmercury (MeHg) efflux from the central nervous system cells, cultured astroglia obtained from neonatal rats were incubated with 10 microM MeHg-cysteine (CySH) for 30 min. After being washed four times, cells were incubated in Hg-free medium, and the release of MeHg from the cells was monitored. The amount of MeHg released in the medium approached a plateau level (ca. 31% of the loaded amount) at 4 hr. Treatment of the cells with a CySH precursor, 2-oxothiazolidine-4-carboxylic acid (OTC), resulted in a significant increase of cellular levels of CySH and glutathione (GSH). OTC also increased 1.5-fold the MeHg efflux from the loaded cells. Another GSH enhancer, GSH isopropyl ester, also stimulated MeHg export from the cells. Ion-exchange column chromatography using DEAE-Sephadex revealed that the MeHg metabolite thus released was exclusively MeHg-GSH conjugate, both with and without OTC. Since the MeHg efflux was suppressed significantly by the presence of probenecid, the efflux occurred via the probenecid-sensitive organic acid transport system. Even though the cellular GSH levels were depleted drastically by treatment with L-buthionine-(S,R)-sulfoximine (BSO), a considerable level (90% of the control) of Hg efflux was detected. Since neither GSH- nor CySH-MeHg was detected in the culture medium of the BSO-treated cells, GSH depletion may trigger some other secretion system(s) in the cells. These results suggest that conjugation with GSH is the major pathway for MeHg efflux in rat astroglia, and that elevation in the cellular GSH level would possibly be a logical therapy for MeHg poisoning, promoting the accelerated elimination of MeHg from the critical tissues.

Animals↗
PubMed1994

Acute effects of methylmercury on hepatic and renal glutathione metabolisms in mice.

Because of its high affinity to the sulfhydryl group, the in vivo fate of methylmercury (MeHg) is closely related to the glutathione (GSH) metabolism. Here, to examine the possible effects of MeHg on the GSH metabolism, C57BL female mice were challenged by this heavy metal at a marginal dose level to induce slight renal dysfunction. Liver and blood GSH levels decreased by 16% and 20%, respectively, 24 h after MeHg (160 mumol/kg) administration, whereas kidney and plasma levels drastically increased. The GSH half-lives obtained using L-buthionine-(S,R)-sulfoximine were shortened by 17% in the liver, but lengthened by 28% in the kidney. The accelerated secretion of GSH from the liver and/or blood cells might have caused increased plasma levels of the tripeptide, which in turn could increase the supply of the constituent amino acids for GSH synthesis to the kidney. Furthermore, renal gamma-glutamylcysteine synthetase activity, a rate-determining enzyme in GSH biosynthesis, was found to be enhanced in the MeHg-treated group. The marked increase in the renal GSH levels induced by MeHg could be due to the increased synthesis and the decreased efflux of the tripeptide in this tissue. The MeHg-induced alterations of GSH metabolism described here might reflect one of the defense mechanisms of bioorganisms against the challenge by MeHg.

Animals↗
PubMed1993

Further study of effects of chelating agents on excretion of inorganic mercury in rats.

The effects of three chelating agents, N-benzyl-D-glucamine dithiocarbamate (BGD), 2,3-dimercaptopropanol (BAL) and D-penicillamine (D-PEN), on the excretion of mercury in rats exposed to mercuric chloride (HgCl2), the chemical forms of mercury compounds excreted in the bile and urine and the intestinal reabsorption of mercury compounds in the bile were studied. Rats were injected intraperitoneally with 203HgCl2 (300 micrograms Hg and 74 kBq of 203Hg/kg) and 24 h later, they were injected intraperitoneally with a chelating agent (a quarter of an LD50). The injection of the chelating agents significantly enhanced the biliary and urinary excretions of mercury. The enhancing effect of BGD on the excretions of mercury was almost the same as that of BAL and much larger than that of D-PEN. The major chemical form of mercury in the bile and urine of rats injected with BGD after HgCl2 treatment was Hg-BGD compounds. The chemical form of mercury in the bile and urine of rats injected with BAL after HgCl2 treatment was mainly Hg-GSH compound. The mercury after HgCl2 and D-PEN treatment was excreted mainly via the urine in the form of Hg-D-PEN compound. The intestinal reabsorption of mercury from the bile of rats injected with BGD or D-PEN was only 0.18% or 0.38% of the dose, respectively. The intestinal reabsorption of mercury from the bile of rats injected with BAL was 27.38% of the dose. It was suggested that the Hg-GSH compound excreted in the bile after HgCl2 and BAL treatment is partly degraded to Hg-cysteine (Cys) by the intestinal membranous enzymes and that the ligand of Hg-Cys is replaced by BAL in the bile, resulting in the effective reabsorption of Hg-BAL compound from the intestine.

Animals↗
PubMed1992

Influence of dietary protein levels on the fate of methylmercury and glutathione metabolism in mice.

We investigated the influence of dietary protein levels on the fate of methylmercury (MeHg), the tissue glutathione (GSH) levels and the efflux rates of GSH in C57BL/6N male mice. One group of mice was fed a 7.5% protein diet (low protein diet, LPD) and the other was fed a 24.8% protein diet (normal protein diet, NPD). The cumulative amount of Hg in urine in LPD-fed mice was approximately 3.7-times lower than in NPD group during the 7 days after oral administration of MeHg (20 mumol/kg), although the fecal Hg levels were identical in the two groups. Hg concentration in kidney, liver and blood decreased time-dependently for 7 days after the administration in both groups of mice, whereas the brain levels continued to increase during this period. Tissue Hg levels in the LPD group were significantly higher than in the NPD group except for the liver. Although the hepatic GSH level in LPD-fed mice was significantly lower than in NPD-fed mice, the levels in the kidney, brain, blood and plasma were not different between the two groups. The efflux rate (mumol/g body weight per day) of hepatic GSH in LPD-fed mice was significantly lower than in the NPD group, whereas the efflux rates of renal GSH were identical in both groups. When MeHg (20 mumol/kg)-pretreated mice were injected with acivicin, a specific inhibitor of gamma-glutamyltranspeptidase, the urinary Hg levels increased by 60- and 36-fold in groups fed LPD and NPD, respectively. As a result, the difference in urinary Hg levels between the two groups disappeared with acivicin treatment. This result indicated that LPD feeding might decrease urinary Hg excretion by increasing the retention of MeHg metabolite(s) in renal cells. Thus, our present study suggested that the dietary protein status, which could modulate the metabolism of thiol compounds, played an important role in determining the fate of MeHg.

Animals↗
PubMed1990

Interaction of methylmercury compounds with albumin.

The nature of interaction between bovine serum albumin (BSA) and methylmercurial compounds has been investigated by ultrafiltration analysis. Four types of BSA samples, mercaptalbumin, its mixed disulfides with glutathione (GSH) and L-cysteine (CySH), and S-carbamidomethylated derivative, were used for binding assays with methylmercury (MM) chloride (MMC) and three kinds of MM mercaptides of low molecular weight thiols, GSH (GS-MM), CySH (CyS-MM) and cysteinylglycine (CG-MM). Among various ligands tested, MMC showed the highest affinity for all BSA species, and the BSA-bound fraction of the ligand did not change with ligand/protein ratio. MMC strongly and stoichiometrically bound to mercaptalbumin even at a molar ratio of 1:1. In contrast, the albumin bound fractions of three other MM ligands increased with concomitant decrease in ligand/protein ratio and with time except for the alkylated albumin, the highest binding being shown by mercaptalbumin. Binding of S-2-nitrophenyl-glutathione, a GSH analog with a hydrophobic S-substituent, to albumin species occurred similarly to that of GS-MM. However, GSH and oxidized glutathione (GSSG) interacted differently with albumin; mercaptalbumin showed the lowest affinity for GSH, and GSSG scarcely interacted with all BSA species. These results suggest that the sulfhydryl group at Cys-34 is not the only site of BSA that interacts with MM compounds and that albumin interacts preferentially with the hydrophobic domains of a mercurial ligand rather than its hydrophilic peptide moiety.

Animals↗